Cogent Biosciences Inc. (COGT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cogent Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$32.23
+0.69% today
Market cap
$5.6B
Overall quality
38/100
Kronos AI 30-day
+5.3%
7 of 8 simulated paths end higher
Cogent Biosciences Inc. (COGT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $5.6B. It trades at $32.23, up 0.69% today. Its overall quality score is 38 out of 100, ranked against the whole US market. 9 analysts' average target of $54.88 implies +70.3% from today's price. Kronos AI's 30-day forecast is +5.3% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $54.88 |
| Low – high | $45.00 – $62.00 |
| Analysts | 9 |
| Upside to average | +70.3% |
Kronos AI 30-day forecast
| Expected close | $33.69 (+5.3%) |
| Likely range | −0.4% … +9.0% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 37 |
| Solvency | 45 |
| Growth | 32 |
| Overall | 38 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.